The RNF170 gene helps cells control calcium signals and clear away proteins that are no longer needed, which is especially important in nerve cells. This gene plays an important role in keeping nerve messages steady. If the gene does not work properly, some people develop inherited nerve conditions with numbness, unsteady walking, balance problems, stiffness, or weakness. Effects vary by the specific variant.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do the work. Other genes mainly direct when certain processes take place, where they happen, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
RNF170Gene function
What if the gene works
The RNF170 gene helps cells control calcium signaling by marking certain proteins for removal. This supports steady communication inside cells, especially in nerve cells.
Risk
What if the gene does not work
Pathogenic variants in the RNF170 gene can cause nerve conditions, most often sensory ataxia with balance problems and reduced feeling in the feet and hands. Milder and more severe variants may differ in age at onset and whether spasticity appears.
Treatment
What does that mean for your treatment
For conditions linked to the RNF170 gene, no RNF170-specific treatment or drug selection approach is currently established in clinical guidelines. Research is exploring the RNF170 gene as a biomarker in some cancers, but this has not led to routine treatment decisions.
Conditions associated with RNF170
Gene function
What if the gene works
Inside your cells, the RNF170 gene supports a routine cleanup process on a membrane system that stores calcium and handles many proteins. Its protein helps place removal tags on selected proteins after they have been used. This steady work helps explain what the RNF170 gene does in cells: it supports protein turnover and keeps calcium messages more controlled.
The RNF170 gene helps your cells place small removal tags on selected proteins. Those tags guide the cell’s recycling system so older or activated proteins can be cleared at the right time.
RNF170 helps manage proteins called IP3 receptors, which act like release switches for stored calcium inside cells. This is part of how the RNF170 gene affects calcium signaling in many types of cells.
After a calcium message has been sent, RNF170 helps remove receptors that have already been activated. This lets cells reset their response so future signals stay organized.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RNF170 gene can change how the protein folds, how stable it is, and how well it tags certain cell proteins for removal. This helps show how RNF170 gene variants affect the protein at a cellular level. A milder change may leave some activity in place, while a more severe variant can greatly reduce this tagging step or stop a working protein from being made at all. That range of effects can help explain why RNF170 related neurologic conditions vary in when they begin and how strongly they show up.
How variants are linked to conditions
Conditions linked to variants of the RNF170 gene are mainly rare inherited nerve conditions. Pathogenic variants in the RNF170 gene can cause sensory ataxia, which often involves unsteady walking and reduced sensation, and some biallelic variants have been linked to childhood-onset hereditary spastic paraplegia. These are uncommon genetic diagnoses, and only specific disease-causing variants are known to have this link.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not directly affect health and simply contribute to natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, particularly when several genes and environmental influences are involved. In some situations, though, a single well-understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the RNF170 gene. If you have an RNF170 gene change and want to understand what it may mean for you or your family, a doctor or genetic counselor can help put that result in context.
Inheritance of RNF170 variants
The inheritance pattern for RNF170-related conditions can differ depending on the specific condition and variant involved. Some RNF170 gene changes are inherited in an autosomal dominant way, which means one altered copy from either parent can be enough to pass the condition on, and each child has a 50% chance of inheriting that variant. Other RNF170 gene changes follow an autosomal recessive pattern, so a child would need to inherit two altered copies, one from each parent. This mixed picture explains why how RNF170 variants are inherited is not the same in every family.
What does my RNF170 result mean for my family?
RNF170 results can have different meanings for family members because this gene has been linked to more than one inherited condition. In some families, a disease-causing RNF170 change follows a dominant pattern, so close relatives such as parents, siblings, and children may also carry it. In other families, RNF170-related disease follows a recessive pattern, which means relatives may be healthy carriers even if they do not have symptoms. The family impact depends on the exact RNF170 change and the condition it is linked to.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant, RNF170 genetic testing uses a blood or saliva sample and reads the RNF170 gene for changes. Results may identify a known disease-causing variant, a benign variant, or a variant of uncertain significance, which means its health effect is not yet clear.
When should I consider getting a genetic test?
Genetic testing for the RNF170 gene may be worth considering if you or close relatives have unexplained balance problems, numbness or loss of feeling, trouble sensing where your feet are, or progressive stiffness and weakness in the legs that seems to run in the family. A confirmed RNF170 change can help explain the cause and clarify inheritance for relatives.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how informative it is depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. With some conditions, especially those affected by many genes, genetic information gives context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly than others, which can change how well it works or how likely side effects are. These differences are common and are one reason the same treatment may help one person but feel too strong, too weak, or less effective in another. Other factors like age, kidney and liver function, and other medicines also play a part.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It studies links between genes and drugs to better explain why the same treatment may work differently from one person to another. With many medicines, genes can influence how strong a drug’s effects are or how the body handles it. This information can support more informed, more individualized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the RNF170 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects are more likely. Questions about medication safety, side effects, or changes in how you feel during treatment are best discussed with your doctor or pharmacist.
History
The RNF170 gene entered the medical literature through studies of families with inherited nerve symptoms, especially sensory ataxia, a condition that can affect balance and body position sense. In the early 2010s, researchers identified a recurrent variant in the RNF170 gene in several affected families, which helped connect a shared pattern of symptoms to one genetic cause. Building on this early work, scientists uncovered more about the gene by finding other RNF170 variants in people with related neurologic conditions, including forms of hereditary spastic paraplegia. Scientific classifications changed as researchers learned more about the gene. What began as a link to a fairly specific inherited neuropathy gradually broadened into a clearer picture of a gene involved in several rare nerve and movement conditions.